Events & Presentations | Sol-Gel

Past Events

Date	Title
Jun 23, 2020 at 11:00 AM EDT	Sol-Gel Technologies at BMO 2020 Prescriptions for Success Healthcare Conference Click here for Webcast
Jun 18, 2020 at 11:40 AM EDT	Sol-Gel Technologies at Raymond James Human Health Innovation Conference Click here for webcast
Jun 02, 2020 at 11:00 AM EDT	Sol-Gel Technologies at Jefferies 2020 Healthcare Conference Click here for webcast
Mar 26, 2020 at 10:30 AM EDT	Sol-Gel Technologies at 2020 Solebury Trout Virtual Investor Conference Click here for webcast
Mar 04, 2020 at 10:40 AM EST	Sol-Gel Technologies at Cowen and Company 40th Annual Health Care Conference Click here for webcast Supporting Materials Cowen and Company 40th Annual Health Care Conference 1.1 MB
Jan 08, 2020 at 8:00 AM EST	Sol-Gel Announces Positive Top-Line Phase 3 Trial Results of Twyneo® for the Treatment of Acne Click here for webcast Supporting Materials Sol-Gel Announces Positive Top-Line Phase 3 Trial Results of Twyneo® for the Treatment of Acne 768.1 KB
Nov 20, 2019 at 10:00 AM GMT	Sol-Gel Technologies at Jefferies London Healthcare Conference Click here for webcast Supporting Materials Jefferies London Healthcare Conference 1 MB
Nov 20, 2019	Sol-Gel at the Dermatology Drug Development Summit Supporting Materials Dermatology Drug Development Summit 1.9 MB
Jul 25, 2019 at 8:30 AM EDT	Sol-Gel Technologies Analyst and Investor Day Click here for webcast Supporting Materials Sol-Gel Technologies Analyst and Investor Day Presentation 2.9 MB
Jul 08, 2019 at 8:30 AM EDT	Sol-Gel Announces Positive Topline Results from Phase 3 Program Evaluating Epsolay® for Moderate-to-Severe Rosacea Click here for webcast Supporting Materials Sol-Gel Announces Positive Top-Line Results from Epsolay® Phase 3 Program in Papulopustular Rosacea 590.9 KB

Date	Title
June 17, 2020	Sol-Gel Corporate Presentation
January 21, 2020	Efficacy and Safety of Microencapsulated Benzoyl Peroxide (E-BPO) Cream, 5% in Papulopustular Rosacea: Results from Two Phase 3, Vehicle-Controlled Trials
January 21, 2020	Twyneo® (Microencapsulated Benzoyl Peroxide 3%, Tretinoin 0.1%) Phase 3 Efficacy and Safety: Results from Two Randomized Controlled Clinical Trials
January 21, 2020	Characterization of Microencapsulated Benzoyl Peroxide (E-BPO) for the Treatment of Papulopustular Rosacea
January 8, 2020	Sol-Gel Announces Positive Top-Line Phase 3 Trial Results of Twyneo® for the Treatment of Acne
July 25, 2019	Sol-Gel Technologies Analyst and Investor Day Presentation
July 8, 2019	Sol-Gel Announces Positive Top-Line Results from Epsolay® Phase 3 Program in Papulopustular Rosacea
February 14, 2018	TWIN Drug Product Candidate Presentation
February 14, 2018	VERED Drug Product Candidate Presentation